Pith. sign in

REVIEW 3 major objections 18 references

An open-source 10-stage LLM pipeline can run systematic review and meta-analysis end-to-end if humans keep five decision gates.

Reviewed by Pith at T0; open to challenge. T0 means a machine referee read the full paper against a public rubric. the ladder, T0–T4 →

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

T0 review · grok-4.5

2026-07-13 10:59 UTC pith:FDNDMZVW

load-bearing objection Honest architecture paper for an open end-to-end SR/MA LLM pipeline; the four differentiators are real on paper, validation is correctly deferred, and it deserves referee time as a methods piece. the 3 major comments →

arxiv 2606.28363 v1 pith:FDNDMZVW submitted 2026-04-05 cs.IR cs.AIcs.DL

meta-pipe: An LLM-agent pipeline for end-to-end automated systematic review and meta-analysis

Hsieh-Ting Lin , Jiunn-Tyng Yeh This is my paper
classification cs.IR cs.AIcs.DL
keywords systematic reviewmeta-analysislarge language modelautomationevidence synthesisartificial intelligenceGRADEnetwork meta-analysis
verification ladder T0 review T1 audit T2 compute T3 formal T4 reserved

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

meta-pipe is a described architecture, not a validated product: a modular 10-stage pipeline that takes a research question from literature search through screening, extraction, statistics, manuscript drafting, and quality checks. It wires Claude models for language-heavy steps, Python for automation, R packages for meta-analysis (including Bayesian and frequentist network methods), and Quarto for rendering. Five forced human stops sit at scope definition, screening disagreements, analysis-type choice, GRADE judgments, and clinical interpretation. The authors claim this combination is the first open-source system to add automated manuscript assembly from real R outputs, semi-automated GRADE, twelve-pattern overclaim scanning, and dual-paradigm network meta-analysis in one place. They report only design and a feature table against five other tools, estimate API cost at $15–30 for a small review, and state that formal Cochrane-reproduction validation is still underway.

Core claim

End-to-end AI-assisted systematic review and meta-analysis is architecturally feasible as an open-source pipeline when stages are modular, data contracts are explicit, and five human decision points remain mandatory. The distinguishing pieces are manuscript generation that reads effect estimates from R files (to avoid hallucinated statistics), semi-automated GRADE, overclaim detection over twelve fixed linguistic patterns, and side-by-side Bayesian and frequentist network meta-analysis with discordance flags.

What carries the argument

The 10-stage skill-module pipeline with standardized inter-stage file contracts (BibTeX, CSV, JSON, Quarto markdown) and five embedded human gates. Each stage is a self-contained prompt-plus-script module; human gates block automatic advance where domain judgment is required.

Load-bearing premise

That documenting modular stages, file schemas, and human gates is enough to establish architectural feasibility for real systematic reviews when no accuracy or end-to-end validation numbers are yet available.

What would settle it

Reproduce a set of published Cochrane reviews with the pipeline and measure screening sensitivity, extraction accuracy, statistical concordance, and GRADE agreement against the original human reviews; if those metrics fall well below current dual-review standards, the feasibility claim fails for routine use.

Watch this falsifier — get emailed when new claim-graph text bears on it.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

3 major / 0 minor

Summary. This manuscript describes meta-pipe, a 10-stage open-source LLM-agent pipeline for end-to-end systematic review and meta-analysis. It integrates Claude (Opus 4 / Haiku 3.5) for screening and extraction, Python automation (~3,600 LOC), R packages (meta, metafor, gemtc, netmeta) for pairwise and dual-paradigm network meta-analysis, and Quarto for IMRaD manuscript rendering, with five mandatory human decision points. The authors report four capabilities they claim are not available in any single existing tool (manuscript generation from R outputs, semi-automated GRADE, 12-pattern overclaim detection, dual-paradigm NMA), a documentation-based comparison with five tools (Table 2), and an estimated API cost of $15–30 per small review. They explicitly frame the work as a system description without validation data and state that Cochrane-reproduction validation is underway.

Significance. If the architecture is as described and the planned validation succeeds, meta-pipe would be a useful open-source contribution: it unifies stages that currently require tool chaining, reads effect estimates from R files into Quarto templates to reduce statistical hallucination, and adds QA layers (GRADE suggestions, overclaim patterns) that existing tools largely omit. The skill-module structure (S2), inter-stage contracts (S3), representative prompts (S1), and explicit human gates are concrete design artifacts that other groups can inspect, reimplement, or interoperate with. The paper is appropriately scoped as architecture rather than accuracy claims, which is a strength for a methods/system description in this area.

major comments (3)
  1. §3.2 and Table 2 uniqueness claims: The four “not available in any single existing tool” differentiators rest on a documentation-only survey (S5) as of March 2026, with no head-to-head runs and with explicit caveats (e.g., otto-SR NMA absence “does not confirm absence”). For a central Results claim, the manuscript should either (a) soften uniqueness language to “not reported in published documentation of the five tools we surveyed” or (b) add a short verification protocol (e.g., what was checked on each tool’s site/docs and date). As written, the claim is stronger than the evidence method supports.
  2. §2.1 / S3 data contracts: Schema validation is “documentation-based; programmatic enforcement is planned.” For a pipeline whose feasibility argument depends on standardized inter-stage contracts (BibTeX/CSV/JSON/Quarto), the absence of even lightweight programmatic checks is load-bearing. Either implement minimal validators for the critical boundaries (03→05→06→07) before acceptance, or reframe “data contracts” as design specifications rather than enforced interfaces so the architectural claim matches the current implementation.
  3. §3.1 / availability: The paper states MIT license and that “repository URL and Zenodo DOI [are] to be added upon acceptance,” but no code, lock files, or runnable example is provided for review. For an open-source system-description paper whose contribution is the pipeline itself, reviewers cannot verify stage modules, scripts, or the claimed ~3,600 LOC. Provide a public or confidential review link (or frozen archive) so the architecture can be inspected against the manuscript.

Circularity Check

0 steps flagged

No circular derivation: architectural feasibility is established by system description, not by a prediction that reduces to its inputs.

full rationale

This is a system-description paper, not a first-principles derivation or empirical prediction study. The central claim—that end-to-end AI-assisted SR/MA is architecturally feasible as an open-source pipeline with five human gates—is supported by the authors’ own 10-stage design, skill-module structure, inter-stage data contracts (BibTeX/CSV/JSON/Quarto), representative prompts, and technology stack (Claude + Python + R + Quarto). That is ordinary methods-paper self-description, not circularity: the “result” is the existence and design of the pipeline they built, not a quantity fitted from data and then re-presented as a prediction. Feature comparison with five tools is documentation-based and explicitly non-validation; thresholds (kappa ≥ 0.60, NMA discordance rules) are stated as pragmatic author choices, not derived uniqueness theorems. No self-citation load-bearing uniqueness claim, no fitted parameter renamed as prediction, and no ansatz smuggled via prior author work. Score 0 is the correct honest finding.

Axiom & Free-Parameter Ledger

4 free parameters · 5 axioms · 3 invented entities

As a system-description paper, load-bearing content is design choices and domain conventions rather than fitted physical constants. Free parameters are pragmatic thresholds the authors chose for gates and discordance. Axioms are standard SR/MA practice plus the design stance that mandatory human gates plus modular contracts equal feasible end-to-end automation. Invented entities are the pipeline modules and the fixed overclaim pattern set, which lack independent external validation in this paper.

free parameters (4)
  • test-retest kappa threshold = 0.60
    Minimum kappa 0.60 at temperature 0.3 used as screening quality gate; author-chosen, below Cochrane dual-review 0.80, and measures intra-model stability not independent raters (§2.3).
  • LLM screening temperature = 0.3
    Temperature 0.3 for two independent screening passes; controls stochastic agreement metric (§2.3).
  • NMA discordance thresholds = >0.2 SMD or OR ratio >1.5
    Reversed top-three rankings or point estimates differing by >0.2 SMD or odds-ratio ratio >1.5 trigger closer examination; stated as pragmatic author-chosen, not calibrated (§2.5).
  • API cost estimate band = $15–30
    Theoretical $15–30 per 5–10 study review from Claude token pricing, not empirical measurement (§3.4).
axioms (5)
  • domain assumption Standard SR/MA workflow stages (PICO, search, screen, extract, RoB, meta-analysis, GRADE, manuscript, PRISMA) are the correct decomposition for end-to-end automation.
    Pipeline stages 00–09 mirror conventional evidence-synthesis practice and PRISMA/Cochrane framing (§2.1, Table 1).
  • domain assumption Mandatory human decision points at five junctures improve trust and appropriateness for de novo questions even if full automation can match humans on some tasks.
    Aligned with Cochrane 2025 AI position and RAISE; authors note this is unproven for overall accuracy (§2.1, §4.3).
  • ad hoc to paper Reading effect estimates from R output files into Quarto templates prevents statistical hallucination in generated manuscripts.
    Core design claim for unique manuscript-generation capability; not empirically stress-tested in this paper (§2.6, §3.2).
  • ad hoc to paper Feature presence/absence in five competitor tools can be fairly assessed from published documentation as of March 2026 without head-to-head runs.
    Table 2 and S5 methodology; authors acknowledge possible unreleased features (§3.3, S5).
  • domain assumption REM L random-effects with Hartung-Knapp, standard heterogeneity/publication-bias tools, and gemtc/netmeta dual NMA are appropriate default statistical engines.
    Stage 06 methods cite standard R packages and practices (§2.5).
invented entities (3)
  • meta-pipe 10-stage skill-module pipeline with inter-stage data contracts no independent evidence
    purpose: Orchestrate full SR/MA from topic intake through QA under human gates.
    The primary artifact; independent evidence of correctness is deferred to planned Cochrane reproduction; code DOI not yet public.
  • 12 predefined overclaim detection patterns no independent evidence
    purpose: Scan manuscript text for unsupported claim styles (causal language on observational data, ignoring heterogeneity, etc.).
    Listed in S4; precision/recall not evaluated; not validated on real clinical reviews (§3.2, §4.5).
  • Dual-paradigm NMA concordance check (gemtc Bayesian + netmeta frequentist) no independent evidence
    purpose: Flag ranking/estimate discordance for human examination.
    Tested with synthetic data only, not a real clinical review (§3.2).

pith-pipeline@v1.1.0-grok45 · 14452 in / 3957 out tokens · 35098 ms · 2026-07-13T10:59:46.885585+00:00 · methodology

0 comments
read the original abstract

Objective: To describe the architecture and design rationale of meta-pipe, an open-source large language model (LLM)-agent pipeline that integrates the complete systematic review and meta-analysis (SR/MA) workflow -- from literature search through statistical analysis, manuscript generation, and quality assurance -- with mandatory human oversight at critical decision points. Study Design and Setting: We developed a 10-stage modular pipeline integrating Claude (Anthropic; Opus 4 for reasoning, Haiku 3.5 for classification) for LLM-assisted screening and extraction, Python (~3,600 lines of code) for automation, R (meta, metafor, gemtc, netmeta) for statistical analysis, and Quarto for manuscript rendering. Five mandatory human decision points enforce oversight. We systematically compared meta-pipe's capabilities with five existing SR automation tools based on published documentation as of March 2026. Results: meta-pipe offers four capabilities not available in any single existing tool: automated manuscript generation from analysis outputs, semi-automated GRADE assessment, overclaim detection (12 predefined patterns), and dual-paradigm network meta-analysis (Bayesian and frequentist). Estimated API cost is $15-30 per typical 5-10 study review. No validation data are reported; this is a system description, not a validation study. Conclusion: End-to-end AI-assisted evidence synthesis is architecturally feasible as an open-source tool with mandatory human oversight. Formal validation reproducing published Cochrane reviews is underway and essential before routine use.

Figures

Figures reproduced from arXiv: 2606.28363 by Hsieh-Ting Lin, Jiunn-Tyng Yeh.

Figure 1
Figure 1. Figure 1: meta-pipe pipeline architecture. The 10-stage workflow proceeds from topic intake (Stage 00) through quality [PITH_FULL_IMAGE:figures/full_fig_p008_1.png] view at source ↗

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

18 extracted references · 7 canonical work pages

  1. [1]

    I. E. Allen, I. Olkin, Estimating time to conduct a meta-analysis from number of citations retrieved, JAMA 282 (7) (1999) 634–635, pMID: 10517715.doi:10.1001/jama.282.7.634

    work page doi:10.1001/jama.282.7.634 1999

  2. [2]

    Michelson, K

    M. Michelson, K. Reuter, The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials, Contemporary Clinical Trials Communications 16 (2019) 100443, pMID: 31497675.doi:10.1016/j.conctc.2019.100443

    doi:10.1016/j.conctc.2019.100443 2019

  3. [3]

    Borah, A

    R. Borah, A. W. Brown, P. L. Capers, K. A. Kaiser, Analysis of the time and workers needed to conduct systematic reviews of medical interventions using data from the PROSPERO registry, BMJ Open 7 (2) (2017) e012545, pMID: 28242767.doi:10.1136/bmjopen-2016-012545

    doi:10.1136/bmjopen-2016-012545 2017

  4. [4]

    Clark, P

    J. Clark, P. Glasziou, C. Del Mar, A. Bannach-Brown, P. Stehlik, A. M. Scott, A full systematic review was completed in 2 weeks using automation tools: a case study, Journal of Clinical Epidemiology 121 (2020) 81–90, pMID: 32004673.doi:10.1016/j.jclinepi.2020.01.008

    work page doi:10.1016/j.jclinepi.2020.01.008 2020

  5. [5]

    Kellermeyer, B

    L. Kellermeyer, B. Harnke, S. Knight, Covidence and Rayyan, Journal of the Medical Library Associ- ation 106 (4) (2018) 580–583.doi:10.5195/jmla.2018.513

    work page doi:10.5195/jmla.2018.513 2018

  6. [6]

    Z. Wang, L. Cao, B. Danek, Q. Jin, Z. Lu, Accelerating clinical evidence synthesis with large lan- guage models, npj Digital Medicine 8 (2025) 414, pMID: 40775042; PMC12331930.doi:10.1038/ s41746-025-01840-7

    2025

  7. [7]

    L. Cao, Z. Wang, Z. Lu, Automation of systematic reviews with large language models, medRxiv preprint. doi: 10.1101/2025.06.13.25329541 (2025)

    doi:10.1101/2025.06.13.25329541 2025

  8. [8]

    K. M. Kallmes, J. Thurnham, M. Sauca, R. Tarchand, K. R. Kallmes, Human-in-the-loop artificial intelligence system for systematic literature review: methods and validations for the AutoLit review software, Cochrane Evidence Synthesis and Methods 3 (2025) e70059, pMID: 41143167; PMC12552804. doi:10.1002/cesm.70059

    work page doi:10.1002/cesm.70059 2025

  9. [9]

    J. L. Lieberum, M. Toews, M. I. Metzendorf, F. Heilmeyer, W. Siemens, C. Haverkamp, D. Böhringer, J. J. Meerpohl, A. Eisele-Metzger, Large language models for conducting systematic reviews: on the rise, but not yet ready for use — a scoping review, Journal of Clinical Epidemiology 181 (2025) 111746, pMID: 40021099.doi:10.1016/j.jclinepi.2025.111746

    doi:10.1016/j.jclinepi.2025.111746 2025

  10. [10]

    Cochrane, Cochrane position statement on the use of artificial intelligence in evidence synthesis, Cochrane Community, available at: community.cochrane.org (2025)

    2025

  11. [11]

    URLhttps://docs.anthropic.com/en/docs/about-claude/models

    Anthropic, The Claude model family: Claude Opus 4, Sonnet 4, and Haiku 3.5, accessed: 2026-04-06 (2025). URLhttps://docs.anthropic.com/en/docs/about-claude/models

    2026

  12. [12]

    Balduzzi, G

    S. Balduzzi, G. Rücker, G. Schwarzer, How to perform a meta-analysis with R: a practical tutorial, Evidence-Based Mental Health 22 (4) (2019) 153–160.doi:10.1136/ebmental-2019-300117

    work page doi:10.1136/ebmental-2019-300117 2019

  13. [13]

    Viechtbauer, Conducting meta-analyses in R with the metafor package, Journal of Statistical Soft- ware 36 (3) (2010) 1–48.doi:10.18637/jss.v036.i03

    W. Viechtbauer, Conducting meta-analyses in R with the metafor package, Journal of Statistical Soft- ware 36 (3) (2010) 1–48.doi:10.18637/jss.v036.i03. 12

    doi:10.18637/jss.v036.i03 2010

  14. [14]

    van Valkenhoef, J

    G. van Valkenhoef, J. Kuiper, gemtc: Network Meta-Analysis Using Bayesian Methods, r package version 1.0-2 (2023). URLhttps://CRAN.R-project.org/package=gemtc

    2023

  15. [15]

    Balduzzi, G

    S. Balduzzi, G. Rücker, A. Nikolakopoulou, T. Papakonstantinou, G. Salanti, O. Efthimiou, G. Schwarzer, netmeta: An R package for network meta-analysis using frequentist methods, Journal of Statistical Software 106 (2) (2023) 1–40.doi:10.18637/jss.v106.i02

    work page doi:10.18637/jss.v106.i02 2023

  16. [16]

    J. R. Landis, G. G. Koch, The measurement of observer agreement for categorical data, Biometrics 33 (1) (1977) 159–174, pMID: 843571.doi:10.2307/2529310

    doi:10.2307/2529310 1977

  17. [17]

    J. A. C. Sterne, A. J. Sutton, J. P. A. Ioannidis, N. Terrin, D. R. Jones, J. Lau, J. Carpenter, G. Rücker, R. M. Harbord, C. H. Schmid, J. Tetzlaff, J. J. Deeks, J. Peters, P. Macaskill, G. Schwarzer, S. Duval, D. G. Altman, D. Moher, J. P. T. Higgins, Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised con...

    work page doi:10.1136/bmj.d4002 2011

  18. [18]

    See: methods.cochrane.org (2025)

    RAISE Consortium, RAISE: Responsible AI in systematic evidence synthesis guidelines, in develop- ment; Cochrane-affiliated. See: methods.cochrane.org (2025). 13

    2025